adventitious agents
A Guide to Ensure FDA Audits & Inspections are Successful
April 23 by Pharmaceuticals & Biotechnology EditorHow can FDA Audits & Inspections for FDF (Finished Dosage Form) manufacturers be successful? Know the process and requirements. A general understanding and overview of FDA...
Mitigating the Risks of Contamination in Biopharma
October 18 by Pharma IQA crucial consideration in any pharmaceutical manufacturing process, and particularly when work involves biological elements, is how to mitigate the risk of contamination. Experts predict that within...
62.5% of Biologics Professionals Have Strategy in Place to Mitigate Risks of Contamination
September 06 by Pharma IQWithin the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book. As innovation brings down production costs a...
The Biggest Threats to the Safety of Biologics
August 17 by Andrea CharlesDr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Andrea Charles from Pharma, IQ to discuss the biggest threats to the safety of biologics and which contaminants pr...
Ensuring Adventitious Agent Safety in Biologics
July 26 by Pharma IQBy 2015, the global market for biologics is expected to reach $239 billion (£147 billion), thanks to more comprehensive drugs pipelines, development of biosimilars and innovations to slash production...